185 related articles for article (PubMed ID: 24519527)
1. Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells.
Muenyi CS; Trivedi AP; Helm CW; States JC
Toxicol Sci; 2014 May; 139(1):74-82. PubMed ID: 24519527
[TBL] [Abstract][Full Text] [Related]
2. Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.
Muenyi CS; Pinhas AR; Fan TW; Brock GN; Helm CW; States JC
Toxicol Sci; 2012 May; 127(1):139-49. PubMed ID: 22331493
[TBL] [Abstract][Full Text] [Related]
3. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC).
Muenyi CS; States VA; Masters JH; Fan TW; Helm CW; States JC
J Ovarian Res; 2011 Jun; 4():9. PubMed ID: 21696631
[TBL] [Abstract][Full Text] [Related]
4. The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog.
He G; Kuang J; Khokhar AR; Siddik ZH
Gynecol Oncol; 2011 Aug; 122(2):402-9. PubMed ID: 21592546
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad.
Strait KA; Warnick CT; Ford CD; Dabbas B; Hammond EH; Ilstrup SJ
Mol Cancer Ther; 2005 Apr; 4(4):603-11. PubMed ID: 15827334
[TBL] [Abstract][Full Text] [Related]
6. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
[TBL] [Abstract][Full Text] [Related]
7. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent.
McNeely SC; Taylor BF; States JC
Toxicol Appl Pharmacol; 2008 Aug; 231(1):61-7. PubMed ID: 18501396
[TBL] [Abstract][Full Text] [Related]
8. Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.
Li B; Gao Y; Rankin GO; Rojanasakul Y; Cutler SJ; Tu Y; Chen YC
Cancer Lett; 2015 Jan; 356(2 Pt B):418-33. PubMed ID: 25304379
[TBL] [Abstract][Full Text] [Related]
9. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
Perego P; Gatti L; Righetti SC; Beretta GL; Carenini N; Corna E; Dal Bo L; Tinelli S; Colangelo D; Leone R; Apostoli P; Lombardi L; Beggiolin G; Piazzoni L; Zunino F
Int J Cancer; 2003 Jul; 105(5):617-24. PubMed ID: 12740909
[TBL] [Abstract][Full Text] [Related]
10. Arsenite-induced apoptosis is prevented by selenite in A375 cell line.
Wang ZF; Guo X
Biol Trace Elem Res; 2011 Apr; 140(1):7-17. PubMed ID: 20390378
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
Pan H; Wang F; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Int J Oncol; 2017 Nov; 51(5):1508-1520. PubMed ID: 29048667
[TBL] [Abstract][Full Text] [Related]
12. Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells.
Kim Y; Jeong IG; You D; Song SH; Suh N; Jang SW; Kim S; Hwang JJ; Kim CS
Anticancer Drugs; 2014 Jan; 25(1):53-62. PubMed ID: 24100277
[TBL] [Abstract][Full Text] [Related]
13. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.
Qu Z; Zou X; Zhang X; Sheng J; Wang Y; Wang J; Wang C; Ji Y
Mol Med Rep; 2016 Feb; 13(2):1336-44. PubMed ID: 26677104
[TBL] [Abstract][Full Text] [Related]
14. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
16. MDM2 sensitizes a human ovarian cancer cell line.
Mi RR; Ni H
Gynecol Oncol; 2003 Aug; 90(2):238-44. PubMed ID: 12893182
[TBL] [Abstract][Full Text] [Related]
17. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
19. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer.
Miow QH; Tan TZ; Ye J; Lau JA; Yokomizo T; Thiery JP; Mori S
Oncogene; 2015 Apr; 34(15):1899-907. PubMed ID: 24858042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
